Liu Y - Search Results

1

[Expression and clinical significance of Nusap1 in hepatical carcinoma].

Zhang M, Yang D, Liu X, Liu Y, Liang J. Zhang M, et al. Among authors: liu y, liu x. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Sep;38(9):876-81. doi: 10.3969/j.issn.1672-7347.2013.09.002. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013. PMID: 24071699 Chinese.

2

[Safety and efficacy of Sorafenib in treatment of tumor recurrence in liver transplantation recipients].

Li XH, Zhong KB, Liu Y, Yang DH, Zhou J. Li XH, et al. Among authors: liu y. Nan Fang Yi Ke Da Xue Xue Bao. 2011 Sep;31(9):1608-10. Nan Fang Yi Ke Da Xue Xue Bao. 2011. PMID: 21945779 Clinical Trial. Chinese.

3

[Expression of SATB1 in hepatocellular carcinoma cell lines with different invasive capacities].

Li G, Yang D, Li X, Zhong K, Liu X, Bi M, Liu Y, Liao X, Lin L. Li G, et al. Among authors: liu y, liu x. Nan Fang Yi Ke Da Xue Xue Bao. 2012 Jun;32(7):986-90, 994. Nan Fang Yi Ke Da Xue Xue Bao. 2012. PMID: 22820583 Chinese.

4

[Association of cellular inhibitor of apoptosis protein-2 expression with clinical outcomes of hepatocellular carcinoma].

Bi M, Yang D, Li X, Zhong K, Liu Y, Li G, Liao X, Liu X. Bi M, et al. Among authors: liu y, liu x. Nan Fang Yi Ke Da Xue Xue Bao. 2012 Jun;32(7):1020-5, 1030. Nan Fang Yi Ke Da Xue Xue Bao. 2012. PMID: 22820591 Chinese.

5

[Expression of Nusap1 in the surgical margins of hepatocellular carcinoma and its association with early recurrence].

Zhang M, Yang D, Liu X, Liu Y, Liang J, He H, Zhong K, Lin L, Tao G, Zhang C, Zhou J. Zhang M, et al. Among authors: liu y, liu x. Nan Fang Yi Ke Da Xue Xue Bao. 2013 Jun;33(6):937-8, inside back cover. Nan Fang Yi Ke Da Xue Xue Bao. 2013. PMID: 23803217 Chinese.

6

[Adult-to-adult living-related donor liver transplantation: report of 2 cases].

Yang DH, Zhou J, Li XH, Lin JH, Liu Y, Wang Y, Zhang GW, Cui ZL, Tan YF, Lin YX, Zhang QF, Kan HP, Liao CX, Fang XJ. Yang DH, et al. Among authors: liu y. Nan Fang Yi Ke Da Xue Xue Bao. 2011 Dec;31(12):2061-6. Nan Fang Yi Ke Da Xue Xue Bao. 2011. PMID: 22200713 Chinese.

7

[High expression of DNMT3B promotes proliferation and invasion of hepatocellular carcinoma cells via Hippo signaling pathway].

Dong G, Qiu F, Liu C, Wu H, Liu Y. Dong G, et al. Among authors: liu y, liu c. Nan Fang Yi Ke Da Xue Xue Bao. 2019 Dec 30;39(12):1443-1452. doi: 10.12122/j.issn.1673-4254.2019.12.08. Nan Fang Yi Ke Da Xue Xue Bao. 2019. PMID: 31907153 Free PMC article. Chinese.

8

Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma.

Liu Y, Wu H, Mei Y, Ding X, Yang X, Li C, Deng M, Gong J. Liu Y, et al. Sci Rep. 2017 Nov 10;7(1):15294. doi: 10.1038/s41598-017-14813-y. Sci Rep. 2017. PMID: 29127353 Free PMC article. Clinical Trial.

9

Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma.

Wu H, Liu Y, Jiang XW, Li WF, Guo G, Gong JP, Ding X. Wu H, et al. Among authors: liu y. Tumour Biol. 2016 Oct;37(10):13499-13508. doi: 10.1007/s13277-016-5211-y. Epub 2016 Jul 28. Tumour Biol. 2016. PMID: 27465555

10

Comparison of clinicopathological traits and prognostic factors of hepatocellular carcinoma with and without cirrhotic background.

Hu J, Zhang ZQ, Zhu W, Wu ZR, You Y, Liu Y, Su DW, Wang YB, Gong JP. Hu J, et al. Among authors: liu y. Carcinogenesis. 2020 Nov 13;41(11):1576-1582. doi: 10.1093/carcin/bgaa024. Carcinogenesis. 2020. PMID: 32188964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209,193 results

Search Page

Filters